Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study
- 14 December 2019
- journal article
- research article
- Published by Wiley in The Breast Journal
- Vol. 26 (7) , 1296-1301
Abstract
Chemotherapy‐induced alopecia (CIA) affects the majority of patients receiving chemotherapy (CT) for early breast cancer. It is a highly distressing side effect of CT, with psychological and social impact. Primary aim of the present analysis was to assess the efficacy of scalp cooling with DigniCap® in preventing CIA. Success rate was defined as patients’ self‐reported hair loss P < .001). The type of CT was: docetaxel‐cyclophosphamide (26%), paclitaxel (23%), epirubicin‐cyclophosphamide followed by paclitaxel (32%), and paclitaxel followed by epirubicincyclophosphamide (19%). The rate of success in preventing alopecia was 77% (104/135) at 3 weeks from the start of CT and 60% (81/135) at 3 weeks from the end of treatment. Higher success rates were reported in non‐anthracycline (71%) compared to anthracycline‐containing CT regimens (54%; P < 0.001). Premature discontinuation of scalp cooling was reported in 29/135 patients (21.5%), including withdrawal for alopecia (16/29), for low scalp cooling tolerability (8/29) or both (5/29). Scalp cooling was generally well tolerated. These results overall suggest that the use of scalp cooling is effective in preventing alopecia in the majority of early breast cancer patients receiving neoadjuvant or adjuvant CT, especially for patients undergoing a taxane‐based non‐anthracycline regimen.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy of interventions for prevention of chemotherapy‐induced alopecia: A systematic review and meta‐analysisInternational Journal of Cancer, 2014
- Pathobiology of chemotherapy-induced hair lossThe Lancet Oncology, 2013
- Chemotherapy-induced alopeciaJournal of the American Academy of Dermatology, 2012
- Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling RegistryActa Oncologica, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Treatment of chemotherapy-induced alopeciaDermatologic Therapy, 2011
- Impact of alopecia and scalp cooling on the well‐being of breast cancer patientsPsycho-Oncology, 2010
- Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp coolingBreast Cancer Research and Treatment, 2009
- Hair and cancer chemotherapy: consequences and nursing care - a literature studyEuropean Journal of Cancer Care, 2001
- Prevention of Doxorubicin-Induced Hair Loss with Scalp HypothermiaNew England Journal of Medicine, 1979